Kt/Vurea and nonurea small solute levels in the hemodialysis study

Journal of the American Society of Nephrology

Volumn 27, Issue 11, 2016, Pages 3469-3478

  Meyer, Timothy W ^a   Sirich, Tammy L ^a   Fong, Kara D ^a   Plummer, Natalie S ^a   Shafi, Tariq ^b   Hwang, Seungyoung ^b   Banerjee, Tanushree ^c   Zhu, Yunnuo ^c   Powe, Neil R ^c   Hai, Xin ^d   Hostetter, Thomas H ^d  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 N,N' DIMETHYLARGININE; HIPPURIC ACID; INDICAN; METHYLGUANIDINE; N(G),N(G) DIMETHYLARGININE; ORGANIC COMPOUND; PARA CRESOL; PARA CRESOL SULFATE; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; UREA; HEMODIALYSIS FLUID;

ADULT; ARTICLE; BODY SURFACE; CAUSE OF DEATH; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOLUTE; TREATMENT FAILURE; CHEMISTRY; METABOLISM;

FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; UREA;

EID: 84982105236     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015091035     Document Type: Article

References (44)

1. Hemodialysis Adequacy 2006Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48[Suppl 1]: S2-S90, 2006
2. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13: 1061-1066, 2002
3. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
4. Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, Kusek JW, Leung J, Burrowes JD,McLeroy SL, Poole D, Uhlin L; HEMO Study Group: The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: Results of the HEMOStudy. Kidney Int 65: 2321-2334, 2004
5. Meyer TW, Sirich TL, Hostetter TH: Dialysis cannot be dosed. Semin Dial 24: 471-479, 2011
6. Duranton F, CohenG,De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A; European Uremic Toxin Work Group: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 23: 1258-1270, 2012
7. Sirich TL, Funk BA, Plummer NS, Hostetter TH, Meyer TW: Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion. J Am Soc Nephrol 25: 615-622, 2014
8. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28: 526-534, 1985
9. Himmelfarb J: The HEMO study-where do we go from here? Curr Opin Nephrol Hypertens 12: 587-591, 2003
10. Levin N, Greenwood R: Reflections on the HEMO study: The American viewpoint. Nephrol Dial Transplant 18: 1059-1060, 2003
11. Locatelli F: Dose of dialysis, convection and haemodialysis patients outcome-what the HEMO study doesn't tell us: The European viewpoint. Nephrol Dial Transplant 18: 1061-1065, 2003
12. Ronden RA,Houben AJ, Teerlink T, Bakker JA, Bierau J, Stehouwer CD, De Leeuw PW, Kroon AA: Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency. Am J Physiol Renal Physiol 303: F149-F156, 2012
13. Schepers E, Speer T, Bode-Böger SM, Fliser D, Kielstein JT: Dimethylarginines ADMA and SDMA: The real water-soluble small toxins? Semin Nephrol 34: 97-105, 2014
14. Rodionov RN, Martens-Lobenhoffer J, Brilloff S, Burdin DV, Jarzebska N, Demyanov AV, Hohenstein B,Weiss N, Bode-Böger SM: Acetylation of asymmetric and symmetric dimethylarginine: An undercharacterized pathway of metabolism of endogenous methylarginines. Nephrol Dial Transplant 31: 57-63, 2016
15. Schepers E, Barreto DV, Liabeuf S, Glorieux G, Eloot S, Barreto FC, Massy Z, Vanholder R; European Uremic Toxin Work Group (EUTox): Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin J Am Soc Nephrol 6: 2374-2383, 2011
16. Siroen MP, van der Sijp JR, Teerlink T, van Schaik C, Nijveldt RJ, van Leeuwen PA: The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology 41: 559-565, 2005
17. Pham NM, Recht NS, Hostetter TH, Meyer TW: Removal of the proteinbound solutes indican and p-cresol sulfate by peritoneal dialysis. Clin J Am Soc Nephrol 3: 85-90, 2008
18. Poesen R, Viaene L, Verbeke K, Claes K, Bammens B, Sprangers B, Naesens M, Vanrenterghem Y, Kuypers D, Evenepoel P, Meijers B: Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. Clin J Am Soc Nephrol 8: 1508-1514, 2013
19. Gonella M, Barsotti G, Lupetti S, Giovannetti S: Factors affecting the metabolic production of methylguanidine. Clin Sci Mol Med 48: 341-347, 1975
20. Marescau B,NagelsG, Possemiers I,De BroeME, Becaus I, BilliouwJM, Lornoy W, De Deyn PP: Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Metabolism 46: 1024-1031, 1997
21. Eloot S, Torremans A, De Smet R,Marescau B, DeWachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R: Kinetic behavior of urea is different from that of other water-soluble compounds: The case of the guanidino compounds. Kidney Int 67: 1566-1575, 2005
22. Luo FJ, Patel KP, Marquez IO, Plummer NS, Hostetter TH, Meyer TW: Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: A pilot crossover trial.AmJ Kidney Dis 53: 1042-1049, 2009
23. Eloot S, Van BiesenW,GlorieuxG, Neirynck N, Dhondt A, Vanholder R: Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients? PLoS One 8: e76838, 2013
24. Vanholder R, Glorieux G, Eloot S: Once upon a time in dialysis: The last days of Kt/V? Kidney Int 88: 460-465, 2015
25. Hazen SL, Brown JM: Eggs as a dietary source for gut microbial production of trimethylamine-N-oxide. AmJ Clin Nutr 100: 741-743, 2014
26. Meijers BK, De Loor H, Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P: p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 4: 1932-1938, 2009
27. Meyer TW, Hostetter TH: Uremic solutes from colon microbes. Kidney Int 81: 949-954, 2012
28. VaziriND, Zhao YY, Pahl MV:Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: The nature, mechanisms, consequences and potential treatment [published online ahead of print April 16, 2015]. Nephrol Dial Transplant doi: 10.1093/ndt/gfv095
29. DoniaMS, FischbachMA: Human microbiota. Small molecules fromthe human microbiota. Science 349: 1254766, 2015
30. Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P: Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73: 1174-1180, 2008
31. Depner T, Daugirdas J, Greene T, AllonM, BeckG, Chumlea C, Delmez J, Gotch F, Kusek J, Levin N,Macon E,Milford E, OwenW, Star R, Toto R, Eknoyan G; Hemodialysis Study Group: Dialysis dose and the effect of gender and body size on outcome in the HEMOStudy. Kidney Int 65: 1386-1394, 2004
32. Daugirdas JT, Depner TA, Greene T, Kuhlmann MK, Levin NW, Chertow GM, Rocco MV: Surface-area-normalized Kt/V: A method of rescaling dialysis dose to body surface area-implications for differentsize patients by gender. Semin Dial 21: 415-421, 2008
33. Sarkar SR, Kuhlmann MK, Kotanko P, Zhu F, Heymsfield SB, Wang J, Meisels IS, Gotch FA, Kaysen GA, Levin NW: Metabolic consequences of body size and body composition in hemodialysis patients. Kidney Int 70: 1832-1839, 2006
34. Spalding EM, Chandna SM, Davenport A, Farrington K: Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int 74: 348-355, 2008
35. Tripepi G, Mattace Raso F, Sijbrands E, Seck MS, Maas R, Boger R, Witteman J, Rapisarda F,Malatino L,Mallamaci F, ZoccaliC: Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clin J Am Soc Nephrol 6: 1714-1721, 2011
36. Vanholder R, Schepers E, Pletinck A,Nagler EV,GlorieuxG: The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: A systematic review. J Am Soc Nephrol 25: 1897-1907, 2014
37. Lin CJ, Wu V, Wu PC, Wu CJ: Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS One 10: e0132589, 2015
38. Vanholder R, De Smet R, GlorieuxG, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic ToxinWork Group (EUTox): Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 63: 1934-1943, 2003
39. TangWH, Wang Z, Kennedy DJ,Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL: Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 116: 448-455, 2015
40. Sirich TL, Aronov PA, Plummer NS,Hostetter TH,Meyer TW:Numerous protein-bound solutes are cleared by the kidney with high efficiency. Kidney Int 84: 585-590, 2013
41. Depner TA: Prescribing Hemodialysis: A Guide to Urea Modeling, Norwall, MA, Kluwer Academic Publishers, 1991
42. Walther JL, Bartlett DW, Chew W, Robertson CR, Hostetter TH, Meyer TW: Downloadable computer models for renal replacement therapy. Kidney Int 69: 1056-1063, 2006
43. Depner TA, Greene T, Daugirdas JT, Cheung AK, Gotch FA, Leypoldt JK: Dialyzer performance in the HEMO Study: In vivo K0A and true blood flow determined from a model of cross-dialyzer urea extraction. ASAIO J 50: 85-93, 2004
44. Michaels AS: Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans Am Soc Artif Intern Organs 12: 387-392, 1966